MENU
CTNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Contineum Therapeutics (CTNM) Ownership - Who owns Contineum Therapeutics?

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions... Show more

Profile

Industry
N/A
Address
3565 General Atomics Court
Phone
+1 858 333-5280
Employees
51
Web
https://www.contineum-tx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
315.83M
P/E Ratio
-4.88
Total Cash
236.55M
Projected Growth
N/A
Total Debt
6.57M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.29
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Contineum Therapeutics? CTNM symbol Ownership - Tickeron.com